Seller record · breezemeds.com

Breeze Meds

Recorded September 2026 · Standard v1.1

Fails 2 of 8 criteria. S4, compounding disclosure: No text states that the drugs sold are compounded or that compounded drugs lack Food and Drug Administration approval. The word compounded is printed only inside the artwork on five of seven product vial images, and the letters FDA appear nowhere in the 55,343 characters the two live routes publish. 1 more criterion also fails; see the table below.

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling weekly GLP-1 injections, oral semaglutide and tirzepatide, sermorelin and NAD+. Its privacy policy names Breezemeds, LLC and its footer names Breezemeds, Inc., and the two are reconciled on no page read.

Operating entity Breezemeds, LLC

Dispositions

Code	Criterion	Disposition	Where it was read
S1	Prescriber requirement	PASS	breezemeds.com
S2	Prescription gating	PASS	breezemeds.com/consultation?categoryId=weight-loss
S3	Pharmacy identification	PASS	breezemeds.com
S4	Compounding disclosure	FAIL	breezemeds.com
S5	Analytical documentation	FAIL	breezemeds.com
S6	Business address	PASS	breezemeds.com
S7	Price disclosure	PASS	breezemeds.com
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1PASSTwo physicians are named with National Provider Identifier numbers, and the published three-step process puts a medical consultation before delivery. The site calls its providers nationwide rather than United States licensed.Source: breezemeds.com.

S2PASSEligibility questions gate the order. The intake runs ten screens from weight-loss goals to a contraindication screen naming pancreatitis and medullary thyroid carcinoma, and no price or payment screen appears in any of them.Source: breezemeds.com/consultation?categoryId=weight-loss.

S3PASSFour filling pharmacies are named with telephone numbers and web addresses: Belmar Pharmacy, Strive Pharmacy, Epiq Scripts and Casa Pharma Rx. No street address is printed for any of the four.Source: breezemeds.com.

S4FAILNo text states that the drugs sold are compounded or that compounded drugs lack Food and Drug Administration approval. The word compounded is printed only inside the artwork on five of seven product vial images, and the letters FDA appear nowhere in the 55,343 characters the two live routes publish.Source: breezemeds.com.

S5FAILNo certificate, lot number or purity figure appears. Twelve testing terms, including certificate, batch, purity and HPLC, returned zero across the 55,343 characters the two live routes publish.Source: breezemeds.com.

S6PASSThe privacy policy, published as a panel on the homepage rather than as its own route, prints a street address on South Avenue SE in Marietta, Georgia, beside the operating company name and a support address.Source: breezemeds.com.

S7PASSSeven prices are printed on the public homepage before intake, from 100 dollars for sermorelin to 399 dollars for tirzepatide. Six of the seven state a dosing frequency and no billing period, and only the calculator card states a month.Source: breezemeds.com.

S8PASSNo letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: semaglutide injection, tirzepatide injection, oral semaglutide, oral tirzepatide, sermorelin, NAD+ injection, NAD+ nasal spray.

Unpaid link. Breeze Meds does not pay the site, and nothing is earned when it is used. Funding.

Visit Breeze Meds

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.